YTHDF2 and Hepatic fibrosis: CircABHD3 promotes EMT and mitochondrial impairment via facilitating YTHDF2-mediated degradation of YPEL3 mRNA and activating downstream β-catenin signaling, thus exacerbating hepatic fibrosis.